日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Primary and secondary pseudo-stability and progression after atezolizumab with and without bevacizumab

阿特珠单抗联合或不联合贝伐珠单抗治疗后的原发性和继发性假性稳定性及疾病进展

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013727
Govindu, Saiabhiroop; Gowda, Prashanth; Muquith, Maishara; Espinoza, Magdalena; Hsiehchen, David
发表日期：2026
文献求助 收藏

Patient history of cancer in primary care: a closer look among cancer survivors with chronic conditions in federally qualified health centers

初级保健中癌症患者的病史：对联邦认证医疗中心中患有慢性疾病的癌症幸存者的深入研究

期刊:BMC Primary Care
影响因子:2.6
doi:10.1186/s12875-025-02727-y
Booker, Quiera; Eary, Rebecca; Gonzalez, Viviana; Muquith, Maishara; Dev, Pallavi; Lee, Simon J Craddock; Balasubramanian, Bijal A
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing

通过临床测序对癌症基因组中与种族相关的突变进行景观和饱和度分析

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad341
Muquith, Maishara; Hsiehchen, David
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma

肝细胞癌抗PD-1阻断治疗进展后的后续治疗

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-23-0025
Lim, Mir; Muquith, Maishara; Miramontes, Bernadette; Espinoza, Magdalena; Hsiehchen, David
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2023
文献求助 收藏

Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide

全球3期肿瘤临床试验作者中研究者的性别构成

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2022.0031
Muquith, Maishara; Pham, Tri; Espinoza, Magdalena; Hsiehchen, David
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Clinical Efficiency and Safety Outcomes of Virtual Care for Oncology Patients During the COVID-19 Pandemic

新冠疫情期间肿瘤患者远程医疗的临床效率和安全性结果

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.21.00092
Hsiehchen, David; Muquith, Maishara; Haque, Waqas; Espinoza, Magdalena; Yopp, Adam; Beg, Muhammad S
微生物学
新冠
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏